Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT03025360
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of cancer with a NTRK1, NTRK2, or NTRK3 gene fusion
* Subjects are unable to participate in an ongoing larotrectinib clinical trial
* Medically suitable for treatment with larotrectinib
Exclusion Criteria:
* Currently enrolled in an ongoing clinical study of larotrectinib or another TRK inhibitor
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03025360
Study Brief:
Protocol Section:
NCT03025360